$8.50
0.273.28%
At close: Aug 18, 5:00 PM EST
$8.51
0.283.4%
Pre-Market: 7:00 AM EST
Precision BioSciences (DTIL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.70 | $-0.47 | $-1.45 |
| Actual | $-1.26 | $-0.75 | $1.05 | $-1.84 |
| Surprise | -85.3% | -7.14% | +323.4% | -26.9% |
| Revenue | ||||
| Estimate | $1.8M | $4.8M | $10.4M | $7.7M |
| Actual | $0 | $10.8M | $34.2M | $13000 |
| Surprise | -100.0% | +126.7% | +230.0% | -99.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.88 | $-0.96 | $-0.53 |
| Revenue | |||
| Consensus | $1.1M | $1.0M | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.26 | $-0.68 | -85.3 % |
| Q1 | May 5, 2026 | $-0.75 | $-0.70 | -7.14 % |
| Q4 | Mar 12, 2026 | $1.05 | $-0.47 | 323.4 % |
| Q3 | Nov 3, 2025 | $-1.84 | $-1.45 | -26.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $1.78M | -100.0 % |
| Q1 | May 5, 2026 | $10.84M | $4.78M | 126.7 % |
| Q4 | Mar 12, 2026 | $34.20M | $10.37M | 230.0 % |
| Q3 | Nov 3, 2025 | $13.00K | $7.68M | -99.8 % |